Kiniksa Pharmaceuticals International, plc Lease, Cost
Kiniksa Pharmaceuticals International, plc (KNSA) reported Lease, Cost of $5.29 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-24
- Kiniksa Pharmaceuticals International, plc lease, cost for the quarter ending 2023-12-31 was $1.09M, a 17.87% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc lease, cost for the quarter ending 2023-09-30 was $1.53M, a 91.26% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc lease, cost for the quarter ending 2023-06-30 was $1.05M, a 16.96% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc lease, cost for the quarter ending 2022-12-31 was $929.00K.
- Kiniksa Pharmaceuticals International, plc lease, cost for fiscal 2025 was $5.29M, a 11.61% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc lease, cost for fiscal 2024 was $4.74M, a 0.75% decline from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc lease, cost for fiscal 2023 was $4.77M, a 35.88% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc lease, cost for fiscal 2022 was $3.51M, a 15.72% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.29M 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $4.74M 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.63M derived: sum of 2 quarters · filed 2026-02-24 | $3.67M derived: sum of 3 quarters · filed 2026-02-24 | $4.77M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.58M derived: sum of 2 quarters · filed 2023-11-02 | $3.68M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.05M 10-Q · filed 2023-08-01 | $2.15M 10-Q · filed 2023-08-01 | ||
| 2022-12-31 | $929.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.73M derived: sum of 2 quarters · filed 2025-02-25 | $2.63M derived: sum of 3 quarters · filed 2025-02-25 | $3.51M 10-K · filed 2025-02-25 |
| 2022-09-30 | $801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.70M derived: sum of 2 quarters · filed 2023-11-02 | $2.58M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $896.00K 10-Q · filed 2023-08-01 | $1.78M 10-Q · filed 2023-08-01 | ||
| 2021-12-31 | $3.04M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $962.00K derived: sum of 2 quarters · filed 2023-03-02 | $1.35M derived: sum of 3 quarters · filed 2023-03-02 | $1.75M 10-K · filed 2023-03-02 |
| 2020-09-30 | $371.00K 10-Q · filed 2020-11-05 | $764.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.15M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $393.00K 10-Q · filed 2020-08-04 | $783.00K 10-Q · filed 2020-08-04 | ||
| 2019-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $724.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.17M derived: sum of 3 quarters · filed 2022-02-24 | $1.59M 10-K · filed 2022-02-24 |
| 2019-09-30 | $392.00K 10-Q · filed 2020-11-05 | $840.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.26M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $448.00K 10-Q · filed 2020-08-04 | $871.00K 10-Q · filed 2020-08-04 |